Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes
暂无分享,去创建一个
S. Riddell | P. Greenberg | J. Zaia | S. Forman | Chengrong Li | H. Pande | E. McLaughlin‐Taylor | B. Tanamachi
[1] S. Riddell,et al. Development of a Treatment Regimen for Human Cytomegalovirus (CMV) Infection in Bone Marrow Transplantation Recipients by Adoptive Transfer of Donor‐Derived CMV‐Specific T Cell Clones Expanded In Vitro a , 1991, Annals of the New York Academy of Sciences.
[2] S. Riddell,et al. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.
[3] W. Britt,et al. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. , 1991, Journal of immunology.
[4] S. Riddell,et al. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. , 1990, Journal of immunological methods.
[5] U. Koszinowski,et al. Cellular and molecular basis of the protective immune response to cytomegalovirus infection. , 1990, Current topics in microbiology and immunology.
[6] H. Rammensee,et al. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.
[7] H. Ljunggren,et al. Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.
[8] J. Rothman. GTP and methionine bristles , 1989, Nature.
[9] J. Bonifacino,et al. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation , 1989, Nature.
[10] J. Rothbard,et al. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes , 1989, Nature.
[11] J. Berzofsky. Structural basis of antigen recognition by T lymphocytes. Implications for vaccines. , 1988, The Journal of clinical investigation.
[12] M. Bevan,et al. Introduction of soluble protein into the class I pathway of antigen processing and presentation , 1988, Cell.
[13] J. Sissons,et al. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses , 1988, The Journal of experimental medicine.
[14] M. Bevan,et al. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides , 1988, The Journal of experimental medicine.
[15] J. Sissons,et al. Human cytomegalovirus‐specific cytotoxic T cells: their precursor frequency and stage specificity , 1988, European journal of immunology.
[16] U. Koszinowski,et al. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity , 1987, Journal of virology.
[17] M. Gething,et al. Antigen Presentation Pathways to Class I and Class II MHC‐Restricted T Lymphocytes , 1987, Immunological reviews.
[18] B. Dietzschold,et al. A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2 , 1987, The Journal of experimental medicine.
[19] B. Jordan,et al. H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide , 1986, Nature.
[20] A. McMichael,et al. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.
[21] A. Geballe,et al. Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events , 1986, Journal of virology.
[22] J. Sissons,et al. Cytomegalovirus - its cellular immunology and biology. , 1986, Immunology today.
[23] J. Davey,et al. Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.
[24] S. Jonjić,et al. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs , 1985, Journal of virology.
[25] K. Welte,et al. A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. , 1985, Journal of immunology.
[26] A. Riggs,et al. Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Manischewitz,et al. HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections. , 1984, Reviews of infectious diseases.
[28] J. Zaia,et al. Isolation and partial chemical characterization of a 64,000-dalton glycoprotein of human cytomegalovirus , 1984, Journal of virology.
[29] U. Koszinowski,et al. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection , 1984, Nature.
[30] L. Gooding,et al. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. , 1983, Journal of immunology.
[31] L. Borysiewicz,et al. Human cytomegalovirus‐specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity , 1983, European journal of immunology.
[32] J. Manischewitz,et al. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. , 1982, The New England journal of medicine.
[33] M. Stinski,et al. Temporal Patterns of Human Cytomegalovirus Transcription: Mapping the Viral RNAs Synthesized at Immediate Early, Early, and Late Times After Infection , 1982, Journal of virology.
[34] T. Braciale,et al. Stimulation of anti-influenza cytolytic T lymphocytes by CNBr cleavage fragments of the viral hemagglutinin. , 1981, Journal of immunology.
[35] M. Stinski. Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides , 1978, Journal of virology.
[36] T. Merigan,et al. Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection. , 1978, The New England journal of medicine.
[37] P. Neiman,et al. INTERSTITIAL PNEUMONIA AND CYTOMEGALOVIRUS INFECTION AS COMPLICATIONS OF HUMAN MARROW TRANSPLANTATION1 , 1973, Transplantation.